These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 28592405)

  • 1. Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.
    Williamson DA; Carter GP; Howden BP
    Clin Microbiol Rev; 2017 Jul; 30(3):827-860. PubMed ID: 28592405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.
    D'Cunha NM; Peterson GM; Baby KE; Thomas J
    J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical antibiotics and clinical use].
    Cesur S
    Mikrobiyol Bul; 2002; 36(3-4):353-61. PubMed ID: 12838671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The downside of antimicrobial agents for wound healing.
    Punjataewakupt A; Napavichayanun S; Aramwit P
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):39-54. PubMed ID: 30291466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decolonization in Prevention of Health Care-Associated Infections.
    Septimus EJ; Schweizer ML
    Clin Microbiol Rev; 2016 Apr; 29(2):201-22. PubMed ID: 26817630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of superficial bacterial cutaneous infections: a survey among general practitioners in France].
    Fourtillan E; Tauveron V; Binois R; Lehr-Drylewicz AM; Machet L
    Ann Dermatol Venereol; 2013 Dec; 140(12):755-62. PubMed ID: 24315220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?
    Moody MN; Morrison LK; Tyring SK
    Skin Therapy Lett; 2010 Jan; 15(1):1-4. PubMed ID: 20066388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retapamulin: a newer topical antibiotic.
    Dhingra D; Parakh A; Ramachandran S
    J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
    Vingsbo Lundberg C; Frimodt-Møller N
    Int J Antimicrob Agents; 2013 Sep; 42(3):272-5. PubMed ID: 23837927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents for the decolonization of methicillin-resistant Staphylococcus aureus.
    McConeghy KW; Mikolich DJ; LaPlante KL
    Pharmacotherapy; 2009 Mar; 29(3):263-80. PubMed ID: 19249946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
    Weinberg JM; Tyring SK
    J Drugs Dermatol; 2010 Oct; 9(10):1198-204. PubMed ID: 20941943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections.
    Kanagalingam J; Feliciano R; Hah JH; Labib H; Le TA; Lin JC
    Int J Clin Pract; 2015 Nov; 69(11):1247-56. PubMed ID: 26249761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
    Horner C; Mawer D; Wilcox M
    J Antimicrob Chemother; 2012 Nov; 67(11):2547-59. PubMed ID: 22833635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical antimicrobial agents in dermatology].
    Porras-Luque JI
    Actas Dermosifiliogr; 2007 Sep; 98 Suppl 1():29-39. PubMed ID: 18093497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
    Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
    Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of retapamulin, a novel pleuromutilin for topical use.
    Rittenhouse S; Biswas S; Broskey J; McCloskey L; Moore T; Vasey S; West J; Zalacain M; Zonis R; Payne D
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3882-5. PubMed ID: 17065625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo.
    Thum D; Seidl HP; Hein R; Ring J; Andres C; Mempel M
    J Dtsch Dermatol Ges; 2013 Sep; 11(9):875-8. PubMed ID: 23621472
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.
    Doudoulakakis A; Spiliopoulou I; Spyridis N; Giormezis N; Kopsidas J; Militsopoulou M; Lebessi E; Tsolia M
    J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.